uniQure N.V. (QURE)
PHARMACEUTICAL PREPARATIONS
uniQure N.V. (QURE) is listed on Nasdaq, where it has traded since February 5, 2014.
- Listed On
- Nasdaq
- Listed Since
- February 5, 2014
- Employees
- 221
- Market Cap
- $1.7B
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 247 institutions reported holding QURE, with 65.3 million shares worth $3.0 billion in aggregate. The largest reported holder was Avoro Capital Advisors, with 6.7 million shares worth $309.9 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Avoro Capital Advisors | 6,727,777 | $310M | Added 12.89% |
| JPMorgan Chase | 4,867,755 | $231M | Added 71.55% |
| Rtw Investments | 3,941,572 | $182M | Added 52.4% |
| State Street | 2,903,825 | $134M | Added 28.46% |
| Aberdeen Group | 2,848,117 | $131M | Reduced 46.33% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is QURE?
uniQure N.V. (QURE) is listed on Nasdaq, where it has traded since February 5, 2014.
Who are the largest institutional holders of QURE?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of QURE were Avoro Capital Advisors, JPMorgan Chase and Rtw Investments.
How many institutions own QURE?
247 institutions reported a position in QURE for the quarter ended June 30, 2026, worth $3.0 billion in total.
Did institutions buy or sell QURE last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for QURE.
Every reported institutional holder, plus insider and congressional trades in QURE, on SentiSense.